Identification of potential therapeutic targets in prostate cancer through a cross‐species approachSarah Jurmeister(Sarah Cannon Research Institute), David E. Neal(University of Cambridge)EMBO Molecular MedicineFebruary 5, 201810.15252/emmm.201708274Cited by 44SaveCiteExport RISWatch citationsRelated PapersTranscriptomic analysis reveals inhibition of androgen receptor activity by AMPK in prostate cancer cells|Oncotarget|2014|24